Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

IMV

IMV (IMV)

IMV Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:IMV
일자시간출처헤드라인심볼기업
2023/09/0205:00Business WireIMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property AssetsNASDAQ:IMVIMV Inc
2023/07/2620:05Business WireIMV Inc. Announces Update on CCAA Proceedings and Sales and Investment Solicitation ProcessNASDAQ:IMVIMV Inc
2023/05/0905:55Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMVIMV Inc
2023/05/0905:30Business WireIMV Receives NASDAQ Delisting NoticeNASDAQ:IMVIMV Inc
2023/05/0305:15PR Newswire (US)Horizon Technology Finance Announces First Quarter 2023 Financial ResultsNASDAQ:IMVIMV Inc
2023/05/0201:30Business WireIMV Initiates Restructuring Proceedings Under the CCAA to Complete the Review of its Strategic AlternativesNASDAQ:IMVIMV Inc
2023/04/0105:30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMVIMV Inc
2023/04/0105:15Business WireIMV Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:IMVIMV Inc
2023/03/2819:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMVIMV Inc
2023/03/2805:15Business WireIMV Inc. Announces Changes to Its Board of DirectorsNASDAQ:IMVIMV Inc
2023/03/1620:46Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMVIMV Inc
2023/03/1620:10Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:IMVIMV Inc
2023/03/1620:05Business WireIMV Inc. Announces Strategic Update as well as Fourth Quarter and Full Year 2022 Financial and Operational ResultsNASDAQ:IMVIMV Inc
2023/03/0921:05Business WireIMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results and Host a Conference Call and Webcast on March 16, 2023NASDAQ:IMVIMV Inc
2023/02/1502:58Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IMVIMV Inc
2023/02/1400:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMVIMV Inc
2023/02/1321:05Business WireIMV Inc. Presents Positive Initial Results From The MVP-S Phase 2B VITALIZE TrialNASDAQ:IMVIMV Inc
2023/02/0402:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMVIMV Inc
2023/01/0923:59Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMVIMV Inc
2023/01/0907:00Business WireIMV Inc. Announces Update and Planned 2023 Milestones to Advance Clinical Development of its Lead Therapeutic, MVP-SNASDAQ:IMVIMV Inc
2022/12/2207:27Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IMVIMV Inc
2022/12/2104:20Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMVIMV Inc
2022/12/2102:37Business WireIMV Announces Closing of US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:IMVIMV Inc
2022/12/2020:10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMVIMV Inc
2022/12/2007:26Edgar (US Regulatory)Voluntary Supplemental Material Filed Pursuant to Section 11(a) of the Securities Act of 1933 by Foreign Issuers (suppl)NASDAQ:IMVIMV Inc
2022/12/1701:41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMVIMV Inc
2022/12/1622:00Business WireIMV Announces US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:IMVIMV Inc
2022/12/1523:21Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMVIMV Inc
2022/12/1521:05Business WireIMV Inc. Announces Initial Data from the Ongoing Phase 2B VITALIZE Trial in Patients with r/r DLBCLNASDAQ:IMVIMV Inc
2022/12/1323:13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMVIMV Inc
 검색 관련기사 보기:NASDAQ:IMV